Provided by Tiger Trade Technology Pte. Ltd.

Corbus Pharmaceuticals

8.12
+0.02000.25%
Post-market: 8.02-0.1000-1.23%19:31 EST
Volume:457.27K
Turnover:3.71M
Market Cap:142.53M
PE:-1.47
High:8.32
Open:8.15
Low:7.97
Close:8.10
52wk High:20.56
52wk Low:4.64
Shares:17.55M
Float Shares:12.29M
Volume Ratio:1.29
T/O Rate:3.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.5180
EPS(LYR):-3.6837
ROE:-55.65%
ROA:-34.69%
PB:1.55
PE(LYR):-2.20

Loading ...

Corbus Pharmaceuticals Board Member Alan Holmer Resigns Effective December 31

Reuters
·
Dec 19

Corbus Pharmaceuticals Holdings Inc. Stock Slides 5.9%, Underperforms Peers

Dow Jones
·
Dec 18

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Dec 16

Cormorant Asset Management Reports Sale of Corbus Pharmaceuticals Common Shares

Reuters
·
Dec 16

Corbus Pharmaceuticals Holdings Inc. Stock Slides 5.7%, Underperforms Peers

Dow Jones
·
Dec 12

Corbus Pharmaceuticals Holdings Inc - Crb-913 Safe and Well-Tolerated Across All Doses

THOMSON REUTERS
·
Dec 11

Corbus Pharmaceuticals Reports Results From Phase 1a Study of Oral CB1 Inverse Agonist Crb-913 for the Treatment for Obesity Demonstrating Favorable Safety Profile and Emerging Evidence of Weight Loss

THOMSON REUTERS
·
Dec 11

Corbus Pharmaceuticals Holdings Inc - 12-Week Dose-Finding Study Initiated, Completion Expected Summer 2026

THOMSON REUTERS
·
Dec 11

Corbus Pharmaceuticals Holdings Inc - Placebo-Adj Weight Loss of 2.9% Observed at Day 14

THOMSON REUTERS
·
Dec 11

Corbus Pharmaceuticals to Report Results from Phase 1a Study of Oral CB1 Inverse Agonist CRB-913 for the Treatment for Obesity on Thursday, December 11, 2025

GlobeNewswire
·
Dec 11

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Dec 09

Corbus Pharmaceuticals Holdings Inc. Stock Slides 4.2%, Underperforms Peers

Dow Jones
·
Dec 06

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Dec 04

Corbus Pharmaceuticals Holdings Inc. Stock Slides 4.4%, Underperforms Market

Dow Jones
·
Dec 03

Corbus Pharmaceuticals Holdings Inc. Stock Slips 6.8%, Underperforms Peers

Dow Jones
·
Dec 02

Corbus Pharmaceuticals Holdings Inc. Stock Sheds 2.9%, Underperforms Peers

Dow Jones
·
Nov 29

Corbus Pharmaceuticals Holdings Inc. Stock Advances 4.5%, Outperforms Market

Dow Jones
·
Nov 27

Corbus Pharmaceuticals Holdings Inc. Stock Slips 4.7%, Underperforms Peers

Dow Jones
·
Nov 25

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Nov 21

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Nov 19